Using Elestrin Therapy
Discreet and Easy-to-Use
Using Elestrin therapy is easy. Elestrin is a colorless, non-staining, quick-drying gel that you spread on a small area of your upper arm once a day. It also comes in a metered-dose pump, so you can be confident that one pre-measured dose of Elestrin is released each time you press the pump down. Because Elestrin is a topical product, you should not let others come into contact with your Elestrin-treated skin. Make sure, too, to wash your hands thoroughly after application of Elestrin. Learn more about how to apply Elestrin below:
Flexible and convenient dosing options
Important things to remember about using Elestrin
How to Apply Elestrin1
Flexible and Convenient Dosing Options
Elestrin offers the convenience of two low-dose2 options. You will receive a prescription from your healthcare provider for either a 1-pump (0.87 grams) per day dose of Elestrin or a 2-pump (1.7 grams) per day dose of Elestrin. Your healthcare provider may move your dosage up or down depending upon the severity and frequency of your hot flashes.
Important Things to Remember When Using Elestrin:
- Use Elestrin exactly how your healthcare provider tells you
- Always move the spout into the locked position and place the cap over the top of the pump after each use
- Never apply Elestrin to the breast. Never apply Elestrin in or around the vagina
- Do not allow others to apply the gel for you or come in contact with the area where you applied the gel for at least two hours after application
- After application of the gel, wait at least 25 minutes before applying sunscreen to the same area
- Avoid fire, flames or smoking until the gel has dried. Elestrin contains alcohol. Alcohol based gels are flammable
All estrogen therapy has risks. Please see important safety information at the bottom of this page.
Indication
Elestrin is indicated for the treatment of moderate-to-severe hot flashes and night sweats associated with menopause.
Important Safety Information
Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia (decline in memory or thinking skills). Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of cancer of the uterus (womb).
Elestrin should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past; currently have or have had blood clots; currently have or have had liver problems; or think you may be or know that you are pregnant.
The most frequently reported adverse events in clinical trials were nose and throat irritation, breast tenderness, upper respiratory tract infection, and irregular menstrual bleeding.
You and your healthcare provider should discuss whether Elestrin is right for you or whether you still need treatment with Elestrin.
Estrogens, with or without progestins, should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.
Please see full Prescribing Information, including Boxed Warning and Patient Information Sheet.
You are encouraged to report negative side effects of prescription drugs to the FDA (Food and Drug Administration).
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
For more information, call 1-800-890-3098.
References
- Elestrin (estradiol gel) full Prescribing Information. Azur Pharma, Philadelphia, PA, July 2010.
- Simon JA, Bouchard C, Waldbaum A, et al. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women. Obstet Gynecol. 2007;109:588-96.